Group 1 - The core viewpoint of the news is that Daoshi Technology is investing in Brain Family Inc. to enhance its capabilities in AI and new materials, particularly in the application of brain-computer interface technology [1] - Daoshi Technology's subsidiary, Hong Kong Jiana, plans to invest $30 million in Brain Family Inc. to acquire minority shareholder rights [1] - Brain Family Inc. is recognized as one of the "Six Little Dragons of Hangzhou" and specializes in non-invasive brain-computer interface technology, with over 460 authorized patents and products certified by FDA and CE [1] Group 2 - Daoshi Technology, established in 2007 and listed in 2014, focuses on carbon materials, lithium battery materials, and ceramic materials, with major products including graphene conductive agents and ceramic inks [2] - In the first half of 2025, Daoshi Technology reported revenue of 3.654 billion yuan, a year-on-year decrease of 11.64%, while net profit attributable to shareholders increased by 108.16% to 230 million yuan [2] - The significant profit growth is attributed to the expansion of overseas business, increased production capacity of cathode copper, and rising cobalt metal prices, which improved the gross margin of cobalt products [2] Group 3 - Daoshi Technology is establishing an intelligent computing center to integrate atomic-level computing with AI algorithms, aiming to transform traditional material R&D from experience-based to data-driven approaches [3] - The company has formed strategic partnerships with Suzhou Nengsida Electronic Technology Co., Ltd. and Xinpeisen to accelerate the application of carbon materials in key components for humanoid robots [3]

Core Viewpoint - The company announced a significant investment in a leading brain-computer interface technology firm, aiming to enhance its competitive edge and commercial capabilities in various sectors [1] Investment Details - The company's subsidiary, Hong Kong Jiana, signed a Pre-B round preferred stock subscription agreement with Qiangnao Technology and its subsidiaries, committing to invest 30 million USD [1] - The completion of the transaction is subject to approval by Qiangnao Technology's board and specific shareholders [1] Company Profile of Qiangnao Technology - Qiangnao Technology is recognized as a global leader in brain-computer interface technology, possessing unique technological barriers and commercialization capabilities [1] - The core team of Qiangnao Technology includes members from prestigious institutions such as Harvard and MIT, and the company holds over 460 authorized patents [1] - Its core products have received international certifications, including FDA and CE, and are widely applied in fields such as medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1] Strategic Goals - The company aims to leverage Qiangnao Technology's experience in applying brain-computer interface technology to enhance its "AI + new materials" ecosystem and commercialization capabilities [1] - The investment is expected to accelerate the application of the company's carbon material products in key components like electronic skin, thereby strengthening its core competitiveness and supporting long-term stable development [1]

Core Viewpoint - The company, Dao's Technology, has announced a significant investment in a leading brain-computer interface technology firm, Qiangnao Technology, through its subsidiary, Hong Kong Jianna, which aims to enhance its competitive edge and commercial capabilities in various sectors [1] Group 1: Investment Details - Hong Kong Jianna has signed a Pre-B round preferred stock subscription agreement with Qiangnao Technology and related parties, committing to invest 30 million USD to acquire minority shareholder rights in Qiangnao Technology [1] - The completion of the transaction is subject to approval by Qiangnao Technology's board and specific shareholders as per its articles of association [1] Group 2: Company Profile of Qiangnao Technology - Qiangnao Technology is recognized as a global leader in brain-computer interface technology, possessing unique technological barriers and commercialization capabilities [1] - The core team of Qiangnao Technology includes members from prestigious institutions such as Harvard and MIT, and the company holds over 460 authorized patents [1] - Its core products have received international certifications, including FDA and CE, and are widely applied in fields such as medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1] Group 3: Strategic Implications for Dao's Technology - The investment is expected to leverage Qiangnao Technology's experience in applying brain-computer interface technology in medical rehabilitation, educational consumption, and human-computer interaction [1] - This move aims to enhance the company's capabilities in "AI + new materials" ecosystem empowerment and commercialization, while also advancing the application of its carbon material products in key components like electronic skin [1] - The strategic partnership is intended to strengthen the company's core competitiveness and provide robust support for its long-term stable development [1]

Core Insights - Daoshi Technology (300409.SZ) announced that its subsidiary, Hong Kong Jiana Co., Ltd., has signed a Pre-B round preferred stock subscription agreement with Brain Family Inc. and related parties [1] - The transaction will be completed after approval from Brain Family Inc.'s board and specific shareholders [1] - Hong Kong Jiana will invest $30 million to acquire minority equity in Brain Family Inc. [1] Company Overview - Brain Family Inc. is a global leader in brain-computer interface technology, possessing significant technological barriers and commercialization capabilities [1] - The core team of Brain Family Inc. includes members from top institutions such as Harvard and MIT [1] - The company holds over 460 authorized patents and its core products have received international certifications from FDA and CE [1] Application Fields - Brain Family Inc.'s technology is widely applied in various sectors, including medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1]

Core Viewpoint - Daos Technology (300409) announced a significant investment in Strong Brain Technology through its subsidiary Hong Kong Jiana, aiming to enhance its capabilities in AI and new materials applications [1] Group 1: Investment Details - Hong Kong Jiana plans to invest 30 million USD to subscribe to the Pre-B round preferred shares of Strong Brain Technology, acquiring minority shareholder rights [1] - The transaction will be completed after approval from Strong Brain Technology's board and specific shareholders [1] Group 2: Strategic Objectives - The company aims to leverage Strong Brain Technology's expertise in brain-computer interface applications across medical rehabilitation, educational consumption, and human-computer interaction [1] - This investment is intended to strengthen the company's "AI + new materials" ecosystem and commercial implementation capabilities [1] - The company also seeks to advance the application of its carbon material products in key components such as electronic skin [1]

Core Viewpoint - Daoshi Technology (300409.SZ) announced a significant investment in Brain Family Inc. through its subsidiary Hong Kong Jiana, acquiring minority equity in the company by subscribing to Pre-B round preferred shares for $30 million [1] Company Summary - Hong Kong Jiana, a subsidiary of Daoshi Technology, will invest $30 million in Brain Family Inc. to acquire minority shareholder rights [1] - Brain Family Inc. is a leading global company in brain-computer interface technology, possessing unique technological barriers and commercialization capabilities [1] - The core team of Brain Family Inc. includes members from prestigious institutions such as Harvard and MIT, and the company holds over 460 authorized patents [1] - Brain Family Inc.'s core products have received international certifications from FDA and CE, and are widely used in various fields including medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1]

Core Viewpoint - The company is making a strategic investment of $30 million in Qiangnao Technology's Pre-B round preferred shares to acquire minority shareholder rights, aiming to enhance its core competitiveness in the AI and new materials ecosystem [1] Group 1: Investment Details - The investment will be funded using the company's own resources [1] - The investment is targeted at Qiangnao Technology, a leading global company in brain-computer interface technology [1] Group 2: Strategic Rationale - The investment aims to seize opportunities in the AI era [1] - The company seeks to strengthen its capabilities in the commercialization of AI and new materials [1] - The move is expected to enhance the company's core competitiveness [1]

证券代码：300409 证券简称：道氏技术 公告编号：2025-094 广东道氏技术股份有限公司 关于控股子公司对外投资的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 广东道氏技术股份有限公司（以下简称"公司"）控股子公司香港佳纳有 限公司（以下简称 " 香港佳纳" ）于近日与 Brain Family Inc.（以下简称 "标 的公司"、"强脑科技"）及其下属控股子公司（合称"强脑科技"）及其他 相关方共同签订《Pre-B 轮优先股认购协议》（以下简称"认购协议"）。该交 易将在强脑科技根据其章程规定经董事会及特定股东审议通过后完成交割。香 港佳纳使用自有资金出资 3,000.00 万美金认购标的公司 Pre-B 轮优先股，从而 获得标的公司少数股东权益。 一、对外投资概述 二、标的公司的基本情况 强脑科技（Brain Family Inc.）为全球领先的脑机接口技术公司，在脑机接 口领域具备稀缺的技术壁垒和商业化能力。公司核心团队多来自哈佛、MIT 等 顶尖院校，已获授权专利 460 余项，核心产品已通过 FDA、CE 等国际认证， 并广泛应用于医 ...

Group 1 - The core viewpoint of the news is the performance and financial details of Daoshi Technology, which experienced a 5.04% decline in stock price, reaching 21.48 CNY per share, with a total market capitalization of 16.803 billion CNY [1] - Daoshi Technology, established on September 21, 2007, and listed on December 3, 2014, specializes in the production and sale of building ceramic glaze materials, along with providing related technical services and product design [1] - The company's revenue composition includes 47.44% from other businesses, 34.70% from lithium battery materials, 9.00% from carbon materials, and 8.85% from ceramic materials [1] Group 2 - From the perspective of major circulating shareholders, GF Fund's Guangfa CSI 1000 ETF (560010) increased its holdings by 1.0842 million shares in the second quarter, now holding 3.4301 million shares, which is 0.5% of the circulating shares [2] - The estimated floating loss for Guangfa CSI 1000 ETF today is approximately 3.9103 million CNY [2] - Guangfa CSI 1000 ETF, established on July 28, 2022, has a latest scale of 30.718 billion CNY, with a year-to-date return of 27.06% and a one-year return of 63.57% [2]

Core Insights - The company Daoshi Technology (300409) has indicated that its investee company, Chip Pei Sen, is developing atomic computing chips and servers that can be applied in material research, facilitating a shift from traditional trial-and-error methods to AI4S, which is expected to enhance research efficiency and reduce costs [1] Group 1 - The atomic computing chips and servers are aimed at improving material research [1] - The transition to AI4S is anticipated to decrease the frequency of "wet experiments" [1] - Enhanced research efficiency and cost reduction are key benefits of this technology [1]